Plain-English translation of NCT06941012 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
The VaMPiRE study is testing whether specific proteins called α-synuclein and their modifications in your blood can serve as reliable markers for Parkinson's disease. Researchers will collect blood samples and clinical information from about 1,200 people — some with Parkinson's and some without — to see if this blood test can reliably detect the disease early and monitor how it changes over time. This could eventually offer doctors a simple, non-invasive way to diagnose Parkinson's sooner.
Currently, there is no simple blood test to diagnose Parkinson's disease, and early detection remains a major challenge in treating the condition. This study aims to fill that gap by validating a blood-based test that could make diagnosis faster, easier, and more affordable for patients everywhere.
You likely qualify if…
You likely don't qualify if…
As a participant, you would visit the research clinic to have blood samples drawn and complete clinical assessments. The study is observational, meaning researchers will track your health over time without giving you any experimental medication — they are simply collecting samples and monitoring your condition to validate whether the blood test works. You would be part of a larger group being followed longitudinally, helping scientists understand how this potential diagnostic tool performs in real-world patients.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
Greece
Italy
Poland
Spain